Stockreport

Assessing Clinuvel Pharmaceuticals' Valuation As VLRX L Enters Its First Preclinical Dosing Study [Yahoo! Finance]

CLINUVEL PHARMS LTD S/ADR  (CLVLY) 
NASDAQ:AMEX Investor Relations: clinuvel.com/investors
PDF This marks the first formal test of its next-generation delivery technology. See our latest analysis for Clinuvel Pharmaceuticals. Despite the VLRX-L update, Clinuve [Read more]